All News | FDA

Advertising & Promotion

Jun 15, 2016
Pharmacists Join Call To Ban DTC Ads
Jun 14, 2016
Drug Sales Manager, Rep Arrested, Charged With Paying Kickbacks to Physicians in ‘Speaker’ Scheme
Jun 13, 2016
Salix Settles Fraud Case over ‘Sham’ Speaker Programs for $54 Million
Jun 13, 2016
13 Marketing Questions To Ask To Stay Clear of FTC Concerns
Jun 7, 2016
Genentech, OSI Pharmaceuticals Settle False Claims Suit Over Survival Data for $67 Million
Jun 2, 2016
Spinal Implant Device Maker Agrees To Settle Employee’s False Claims Act Allegations
May 31, 2016
Australian Ad Panel Faults Groupon Drug Promotion
May 31, 2016
District Court Drops ‘Off-label’ Claims But Continues False Claims Act Case Against Medtronic
May 27, 2016
Markey Calls for DOJ Investigation of OxyContin’s Longevity Claims
May 27, 2016
Key House Energy and Commerce Members Question FDA’s Lack of Off-label Guidance

Good Clinical Practice

Mar 9, 2017
European Group Recommends Changes to Trial Regs
Mar 9, 2017
FDA Issues Safety Communication on Use of Angioplasty Devices in Treatment of Neurological Disorders
Mar 7, 2017
Public Citizen Opposes Federal Right-to-Try Bills
Mar 6, 2017
Federal Panel Finds Ethical Conditions Have Not Been Met To Allow Zika Human Challenge Trials
Mar 3, 2017
NEJM Review Examines Innovative Informed Consent Techniques
Mar 1, 2017
AstraZeneca, TrialScope Launch Portal for Trial Result Summaries
Feb 22, 2017
W. Va. Delegates Introduce Bill Requiring Universities To Conduct Research if Asked
Feb 22, 2017
Texas Bill Allows Patients To Access Investigational Stem Cell Treatments
Feb 21, 2017
FDA May Soon Have To Confront the Public Release of Clinical Study Reports
Feb 20, 2017
Right-to-Try Measures Introduced in Wisconsin Legislature

FDA Regulation & Enforcement

Jul 25, 2019
Seafood VP Pleads Guilty to Conspiracy To Mislabel Millions of Dollars, Tons of Dollars of Crab
Jul 24, 2019
CBD Maker Receives Warning Letter Over Unsubstantiated Marketing Claims
Jul 24, 2019
NAD Recommends Drop Maker Discontinue Challenged Claims
Jul 19, 2019
OPDP Researchers Move Ahead with Study on Physician Perception of Professional Pieces
Jul 18, 2019
Court Dismisses FCA Case Against Analyzer Maker Over Marketing
Jul 18, 2019
Senators Renew Effort To Enact Legislation Requiring Pricing Info in DTC TV Drug Ads
Jul 18, 2019
Demands for FDA To Act on Plant-Based Labeling Continue Apace
Jul 17, 2019
Court Dismisses Liability Claims Against Drug Makers, Citing Preemption, Pleading Deficiencies
Jul 17, 2019
Health Canada Opens Consultation on Distinction Between Promotional and Non-Promotional Items
Jul 14, 2019
Federal Court Rejects Corrective Advertising Request in Drug Compounding Case

Medical Devices

Mar 31, 2012
FDA Enters Into Consent Decree With Dental Products Maker
Mar 31, 2012
Industry Groups Renew Call To Repeal Device Tax
Feb 29, 2012
Stryker Biotech L.L.C. Pleads Guilty to Misbranding
Feb 29, 2012
FDA, Device Industry Reach Agreement in Principle On User Fees; Deal Includes 'Robust' Review Goals
Feb 29, 2012
Device Firm Settlements With DOJ, SEC Resolve Alleged Foreign Corrupt Practices Act Violations
Feb 29, 2012
5th Circuit: Some Claims Escape Riegel Preemption
Feb 29, 2012
Ombudsman Reports on 2011 Contacts With CDRH by Industry, Others
Feb 29, 2012
Speeding Submission Reviews Is Among CDRH’S Strategic Priorities
Jan 31, 2012
Medtronic Settles False Claims Act Allegations Involving Kickbacks, Studies of Heart Devices
Jan 31, 2012
Postsentencing Rulings Reveal Court's View of 'Patently Illegal' Trials Conducted by Synthes

Copyright © Thompson FDA, a division of CBIS. All rights reserved.